You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Hydrocodone Bitartrate And Homatropine Methylbromide, and when can generic versions of Hydrocodone Bitartrate And Homatropine Methylbromide launch?

Hydrocodone Bitartrate And Homatropine Methylbromide is a drug marketed by Abhai Llc, Actavis Mid Atlantic, Genus, Ivax Sub Teva Pharms, Nostrum Labs Inc, Novel Labs Inc, Padagis Us, Sciegen Pharms Inc, and Wockhardt Bio Ag. and is included in nine NDAs.

The generic ingredient in HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE is homatropine methylbromide; hydrocodone bitartrate. There are five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the homatropine methylbromide; hydrocodone bitartrate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Hydrocodone Bitartrate And Homatropine Methylbromide

A generic version of HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE was approved as homatropine methylbromide; hydrocodone bitartrate by AVANTHI INC on August 7th, 2017.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE?
  • What are the global sales for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE?
  • What is Average Wholesale Price for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE?
Summary for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
US Patents:0
Applicants:9
NDAs:9
Finished Product Suppliers / Packagers: 3
Raw Ingredient (Bulk) Api Vendors: 1
What excipients (inactive ingredients) are in HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE?HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE excipients list
DailyMed Link:HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE at DailyMed
Drug patent expirations by year for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
Pharmacology for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
Drug ClassOpioid Agonist
Mechanism of ActionOpioid Agonists

US Patents and Regulatory Information for HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abhai Llc HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 207487-001 Feb 21, 2017 AA RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Padagis Us HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 205731-001 Feb 15, 2017 AA RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ivax Sub Teva Pharms HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE homatropine methylbromide; hydrocodone bitartrate SYRUP;ORAL 040285-001 Jul 19, 1999 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.